NCT05059158View on ClinicalTrials.gov

Amyloid-β Clearance Mechanisms in Alzheimer's Disease

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

September 30, 2025

Study Completion Date

October 31, 2025

Conditions
Alzheimer's Disease (AD)
Interventions
RADIATION

positron emission tomography (PET)

18-Flutemetamol PET (clinical indicated) is going to be performed at the visit.

Trial Locations (1)

80336

RECRUITING

Klinik und Poliklinik für Psychiatrie und Psychotherapie des LMU Klinikums, München

All Listed Sponsors
lead

Ludwig-Maximilians - University of Munich

OTHER